| Sanofi-Aventis (Suisse) SA - Rilutek, comprimés pelliculés | | 53678 | | 01 | | Rilutek | | comprimés pelliculés | | N07XX02 | | Riluzole | | 17.12.1996 | | |
| | Composition | | riluzolum 50 mg, calcii hydrogenophosphas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, carmellosum natricum conexum, pellicule: hypromellosum, macrogolum 6000, E 171 pro compresso obducto corresp. natrium 0.67 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Riluzole | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Riluzole | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Calcium Hydrogen Phosphate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | pellicule | | Macrogol | 6000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 017 | 56 Tablet(s) | 158.66 | 188.95 | B | SL | No |
|
|
